Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Medical Journal of Mashad University of Medical Sciences. 2010; 52 (4): 220-225
in Persian | IMEMR | ID: emr-93320

ABSTRACT

Cardiac echinococcosis is an uncommon and potentially fatal complication of hydatid cyst disease, which has an intricate diagnosis and treatment because of various presentation, diverse signs and symptoms, and abundant and sometimes unpredictable complications. This study reviewed the results of surgical treatment of 10 cases of cardiac echinococcosis. This case of series was done in ten cases of cardiac echinococcosis underwent surgical treatment at Shahid Madani Heart Hospital, Tabriz, in a 12 years period [1992-2004]. For collecting data a questionnaire was used and statistical analysis was performed with SPSS software and descriptive statistical methods. There were 7 female and 3 male patients [F/M Ratio= 1.75/1]. The mean age of patients was 24.6 years old. All patients operated through median sternotomy with cardiopulmonary bypass. Surgical treatment included puncture of cyst and sterilization with hypertonic saline solution and total cyst extirpation. There was preoperative mortality and cerebral hydatid cyst occurred in another patient one year later. All patients received albendazol pre- and post-operation. According to the results of this study, surgical treatment of cardiac hydatid cyst seems to be a safe approach. It is recommended that patients should receive mebedazole or albendazole for 6 to 24 months after surgery. Reduction of serum levels of antibodies against echinococcus or a negative result signifies a successful treatment


Subject(s)
Humans , Male , Female , Adult , Heart Diseases/surgery , Treatment Outcome , Albendazole , Mebendazole
2.
Iranian Journal of Clinical Infectious Diseases. 2009; 4 (3): 129-134
in English | IMEMR | ID: emr-101147

ABSTRACT

Infective endocarditis is one of the most important complications of injection drug use, which is associated with significant mortality and morbidity. The aim of this study was to evaluate the influence of vegetation size and localization on outcome and in-hospital mortality of infective endocarditis. A total of 34 patients were admitted to a university hospital in a four-year period and analyzed prospectively. Injection drug users were defined as patients who had injected drugs intravenously within the past 3 months before admission. The diagnosis of infective endocarditis was made on the basis of modified Duke's criteria. Totally, 38 episodes of endocarditis in 34 patients were identified. Patients were all male with the mean [ +/- standard deviation] age of 30.4 +/- 7.1 years. The affected valves were as follow: tricuspid valve in 26 cases [74.3%], mitral valve in 4 [11.4%], mitral and tricuspid valve in 4 [11.4%], and mitral and aortic valve in 1 [2.9%]. The vegetation size was 10mm or less in 12 cases [34.29%], and more than 10mm in the remaining 23 cases [65.71%]. Eight patients [21.1%] underwent surgery, however, unfortunately, nine [23.7%] died. Vegetations sized more than 10mm [p<0.033], involvement of the left-sided valves [p<0.012], and presence of more than one vegetation on TTE or TEE [p<0.05] were associated with higher probability of death. In contrast to some earlier studies which concluded that vegetations larger than 20mm are associated with higher mortality, our results revealed that the mortality rate increases even with smaller vegetations. In addition, the number and the location of vegetations also could affect the prognosis. Therefore, lower threshold for surgical interventions should be applied in patients with vegetations larger than 10mm


Subject(s)
Humans , Male , Injections, Intravenous/adverse effects , Treatment Outcome , Anti-Bacterial Agents , Prospective Studies , Aortic Valve Insufficiency/etiology , Mortality , Prognosis , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL